The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Updated results of the phase 1 dose escalation and expansion study of alveltamig (ZG006), a trispecific T cell engager targeting DLL3/DLL3/CD3, as monotherapy in patients with refractory small cell lung cancer or neuroendocrine carcinoma.
 
Qiming Wang
No Relationships to Disclose
 
Jianhua Shi
No Relationships to Disclose
 
Xiaoli Chai
No Relationships to Disclose
 
Li Zheng
No Relationships to Disclose
 
Lihua Wu
No Relationships to Disclose
 
Haibo Mou
No Relationships to Disclose
 
Rongbo Lin
No Relationships to Disclose
 
Xiujuan Qu
No Relationships to Disclose
 
Linlin Liu
No Relationships to Disclose
 
Qi Xu
No Relationships to Disclose
 
Dan Cao
No Relationships to Disclose
 
Yu Yao
No Relationships to Disclose
 
Hanli Shui
Employment - Zelgen
 
Hewen Yin
Employment - Zelgen
 
Liqing Wu
Employment - Zelgen
Leadership - Zelgen
 
Jason Wu
Employment - Zelgen
Leadership - Zelgen
 
Binhua Lyu
Employment - Zelgen
Leadership - Zelgen
 
Andrew Zhu
Employment - Zelgen
Leadership - Zelgen